A significant breakthrough in cancer research is emerging with the use of VHH fragments to re-engage mutated p53. This vital malignant suppressor protein is frequently disabled in many types of tumors, leading https://icelisting.com/story23267900/nanobodies-restore-tumor-suppressor-p53-the-new-hope-for-tumor-management